Selected research
Market Analysis & Forecast
Global Viral Detection Market Analysis and Forecast 2026-2032
Market perspective
The global Viral Detection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Viral Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Viral Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Viral Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Viral Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Viral Detection include Merck KGaA, Charles River Laboratories, Eurofins, SGS, Sartorius, Asahi Kasei, Samsung Biologics, Syngene and Intertek, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Viral Detection, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Viral Detection, also provides the revenue of main regions and countries. Of the upcoming market potential for Viral Detection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Viral Detection revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Viral Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Viral Detection revenue, projected growth trends, production technology, application and end-user industry.
Viral Detection Segment by Company
Merck KGaA
Charles River Laboratories
Eurofins
SGS
Sartorius
Asahi Kasei
Samsung Biologics
Syngene
Intertek
Minaris Advanced Therapies
Texcell
PathoQuest
Clean Cells
Avance Biosciences
Microbiologics
Alcami
Creative Biolabs
Creative Biogene
WuXi AppTec
WuXi Biologics
Viral Detection Segment by Type
Plaque Assays
PCR
ELISA
Others
Viral Detection Segment by Application
Blood & Blood Products
Cellular & Gene Therapy Products
Stem Cell Products
Tissue & Tissue Products
Vaccines and Therapeutics
Viral Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viral Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Viral Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viral Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Viral Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Viral Detection company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Viral Detection revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plaque Assays
- PCR
- ELISA
- Others
Applications
- Blood & Blood Products
- Cellular & Gene Therapy Products
- Stem Cell Products
- Tissue & Tissue Products
- Vaccines and Therapeutics
Companies covered
- Merck KGaA
- Charles River Laboratories
- Eurofins
- SGS
- Sartorius
- Asahi Kasei
- Samsung Biologics
- Syngene
- Intertek
- Minaris Advanced Therapies
- Texcell
- PathoQuest
- Clean Cells
- Avance Biosciences
- Microbiologics
- Alcami
- Creative Biolabs
- Creative Biogene
- WuXi AppTec
- WuXi Biologics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Viral Detection Market by Type
- 1.2.1 Global Viral Detection Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Plaque Assays
- 1.2.3 PCR
- 1.2.4 ELISA
- 1.2.5 Others
- 1.3 Viral Detection Market by Application
- 1.3.1 Global Viral Detection Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Blood & Blood Products
- 1.3.3 Cellular & Gene Therapy Products
- 1.3.4 Stem Cell Products
- 1.3.5 Tissue & Tissue Products
- 1.3.6 Vaccines and Therapeutics
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Viral Detection Market Dynamics
- 2.1 Viral Detection Industry Trends
- 2.2 Viral Detection Industry Drivers
- 2.3 Viral Detection Industry Opportunities and Challenges
- 2.4 Viral Detection Industry Restraints
3 Global Growth Perspective
- 3.1 Global Viral Detection Market Perspective (2021-2032)
- 3.2 Global Viral Detection Growth Trends by Region
- 3.2.1 Global Viral Detection Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Viral Detection Market Size by Region (2021-2026)
- 3.2.3 Global Viral Detection Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Viral Detection Revenue by Players
- 4.1.1 Global Viral Detection Revenue by Players (2021-2026)
- 4.1.2 Global Viral Detection Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Viral Detection Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Viral Detection Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Viral Detection Key Players Headquarters & Area Served
- 4.4 Global Viral Detection Players, Product Type & Application
- 4.5 Global Viral Detection Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Viral Detection Market CR5 and HHI
- 4.6.3 2025 Viral Detection Tier 1, Tier 2, and Tier 3
5 Viral Detection Market Size by Type
- 5.1 Global Viral Detection Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Viral Detection Revenue by Type (2021-2032)
- 5.3 Global Viral Detection Revenue Market Share by Type (2021-2032)
6 Viral Detection Market Size by Application
- 6.1 Global Viral Detection Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Viral Detection Revenue by Application (2021-2032)
- 6.3 Global Viral Detection Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Merck KGaA
- 7.1.1 Merck KGaA Company Information
- 7.1.2 Merck KGaA Business Overview
- 7.1.3 Merck KGaA Viral Detection Revenue and Gross Margin (2021-2026)
- 7.1.4 Merck KGaA Viral Detection Product Portfolio
- 7.1.5 Merck KGaA Recent Developments
- 7.2 Charles River Laboratories
- 7.2.1 Charles River Laboratories Company Information
- 7.2.2 Charles River Laboratories Business Overview
- 7.2.3 Charles River Laboratories Viral Detection Revenue and Gross Margin (2021-2026)
- 7.2.4 Charles River Laboratories Viral Detection Product Portfolio
- 7.2.5 Charles River Laboratories Recent Developments
- 7.3 Eurofins
- 7.3.1 Eurofins Company Information
- 7.3.2 Eurofins Business Overview
- 7.3.3 Eurofins Viral Detection Revenue and Gross Margin (2021-2026)
- 7.3.4 Eurofins Viral Detection Product Portfolio
- 7.3.5 Eurofins Recent Developments
- 7.4 SGS
- 7.4.1 SGS Company Information
- 7.4.2 SGS Business Overview
- 7.4.3 SGS Viral Detection Revenue and Gross Margin (2021-2026)
- 7.4.4 SGS Viral Detection Product Portfolio
- 7.4.5 SGS Recent Developments
- 7.5 Sartorius
- 7.5.1 Sartorius Company Information
- 7.5.2 Sartorius Business Overview
- 7.5.3 Sartorius Viral Detection Revenue and Gross Margin (2021-2026)
- 7.5.4 Sartorius Viral Detection Product Portfolio
- 7.5.5 Sartorius Recent Developments
- 7.6 Asahi Kasei
- 7.6.1 Asahi Kasei Company Information
- 7.6.2 Asahi Kasei Business Overview
- 7.6.3 Asahi Kasei Viral Detection Revenue and Gross Margin (2021-2026)
- 7.6.4 Asahi Kasei Viral Detection Product Portfolio
- 7.6.5 Asahi Kasei Recent Developments
- 7.7 Samsung Biologics
- 7.7.1 Samsung Biologics Company Information
- 7.7.2 Samsung Biologics Business Overview
- 7.7.3 Samsung Biologics Viral Detection Revenue and Gross Margin (2021-2026)
- 7.7.4 Samsung Biologics Viral Detection Product Portfolio
- 7.7.5 Samsung Biologics Recent Developments
- 7.8 Syngene
- 7.8.1 Syngene Company Information
- 7.8.2 Syngene Business Overview
- 7.8.3 Syngene Viral Detection Revenue and Gross Margin (2021-2026)
- 7.8.4 Syngene Viral Detection Product Portfolio
- 7.8.5 Syngene Recent Developments
- 7.9 Intertek
- 7.9.1 Intertek Company Information
- 7.9.2 Intertek Business Overview
- 7.9.3 Intertek Viral Detection Revenue and Gross Margin (2021-2026)
- 7.9.4 Intertek Viral Detection Product Portfolio
- 7.9.5 Intertek Recent Developments
- 7.10 Minaris Advanced Therapies
- 7.10.1 Minaris Advanced Therapies Company Information
- 7.10.2 Minaris Advanced Therapies Business Overview
- 7.10.3 Minaris Advanced Therapies Viral Detection Revenue and Gross Margin (2021-2026)
- 7.10.4 Minaris Advanced Therapies Viral Detection Product Portfolio
- 7.10.5 Minaris Advanced Therapies Recent Developments
- 7.11 Texcell
- 7.11.1 Texcell Company Information
- 7.11.2 Texcell Business Overview
- 7.11.3 Texcell Viral Detection Revenue and Gross Margin (2021-2026)
- 7.11.4 Texcell Viral Detection Product Portfolio
- 7.11.5 Texcell Recent Developments
- 7.12 PathoQuest
- 7.12.1 PathoQuest Company Information
- 7.12.2 PathoQuest Business Overview
- 7.12.3 PathoQuest Viral Detection Revenue and Gross Margin (2021-2026)
- 7.12.4 PathoQuest Viral Detection Product Portfolio
- 7.12.5 PathoQuest Recent Developments
- 7.13 Clean Cells
- 7.13.1 Clean Cells Company Information
- 7.13.2 Clean Cells Business Overview
- 7.13.3 Clean Cells Viral Detection Revenue and Gross Margin (2021-2026)
- 7.13.4 Clean Cells Viral Detection Product Portfolio
- 7.13.5 Clean Cells Recent Developments
- 7.14 Avance Biosciences
- 7.14.1 Avance Biosciences Company Information
- 7.14.2 Avance Biosciences Business Overview
- 7.14.3 Avance Biosciences Viral Detection Revenue and Gross Margin (2021-2026)
- 7.14.4 Avance Biosciences Viral Detection Product Portfolio
- 7.14.5 Avance Biosciences Recent Developments
- 7.15 Microbiologics
- 7.15.1 Microbiologics Company Information
- 7.15.2 Microbiologics Business Overview
- 7.15.3 Microbiologics Viral Detection Revenue and Gross Margin (2021-2026)
- 7.15.4 Microbiologics Viral Detection Product Portfolio
- 7.15.5 Microbiologics Recent Developments
- 7.16 Alcami
- 7.16.1 Alcami Company Information
- 7.16.2 Alcami Business Overview
- 7.16.3 Alcami Viral Detection Revenue and Gross Margin (2021-2026)
- 7.16.4 Alcami Viral Detection Product Portfolio
- 7.16.5 Alcami Recent Developments
- 7.17 Creative Biolabs
- 7.17.1 Creative Biolabs Company Information
- 7.17.2 Creative Biolabs Business Overview
- 7.17.3 Creative Biolabs Viral Detection Revenue and Gross Margin (2021-2026)
- 7.17.4 Creative Biolabs Viral Detection Product Portfolio
- 7.17.5 Creative Biolabs Recent Developments
- 7.18 Creative Biogene
- 7.18.1 Creative Biogene Company Information
- 7.18.2 Creative Biogene Business Overview
- 7.18.3 Creative Biogene Viral Detection Revenue and Gross Margin (2021-2026)
- 7.18.4 Creative Biogene Viral Detection Product Portfolio
- 7.18.5 Creative Biogene Recent Developments
- 7.19 WuXi AppTec
- 7.19.1 WuXi AppTec Company Information
- 7.19.2 WuXi AppTec Business Overview
- 7.19.3 WuXi AppTec Viral Detection Revenue and Gross Margin (2021-2026)
- 7.19.4 WuXi AppTec Viral Detection Product Portfolio
- 7.19.5 WuXi AppTec Recent Developments
- 7.20 WuXi Biologics
- 7.20.1 WuXi Biologics Company Information
- 7.20.2 WuXi Biologics Business Overview
- 7.20.3 WuXi Biologics Viral Detection Revenue and Gross Margin (2021-2026)
- 7.20.4 WuXi Biologics Viral Detection Product Portfolio
- 7.20.5 WuXi Biologics Recent Developments
8 North America
- 8.1 North America Viral Detection Revenue (2021-2032)
- 8.2 North America Viral Detection Revenue by Type (2021-2032)
- 8.2.1 North America Viral Detection Revenue by Type (2021-2026)
- 8.2.2 North America Viral Detection Revenue by Type (2027-2032)
- 8.3 North America Viral Detection Revenue Share by Type (2021-2032)
- 8.4 North America Viral Detection Revenue by Application (2021-2032)
- 8.4.1 North America Viral Detection Revenue by Application (2021-2026)
- 8.4.2 North America Viral Detection Revenue by Application (2027-2032)
- 8.5 North America Viral Detection Revenue Share by Application (2021-2032)
- 8.6 North America Viral Detection Revenue by Country
- 8.6.1 North America Viral Detection Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Viral Detection Revenue by Country (2021-2026)
- 8.6.3 North America Viral Detection Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Viral Detection Revenue (2021-2032)
- 9.2 Europe Viral Detection Revenue by Type (2021-2032)
- 9.2.1 Europe Viral Detection Revenue by Type (2021-2026)
- 9.2.2 Europe Viral Detection Revenue by Type (2027-2032)
- 9.3 Europe Viral Detection Revenue Share by Type (2021-2032)
- 9.4 Europe Viral Detection Revenue by Application (2021-2032)
- 9.4.1 Europe Viral Detection Revenue by Application (2021-2026)
- 9.4.2 Europe Viral Detection Revenue by Application (2027-2032)
- 9.5 Europe Viral Detection Revenue Share by Application (2021-2032)
- 9.6 Europe Viral Detection Revenue by Country
- 9.6.1 Europe Viral Detection Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Viral Detection Revenue by Country (2021-2026)
- 9.6.3 Europe Viral Detection Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Viral Detection Revenue (2021-2032)
- 10.2 China Viral Detection Revenue by Type (2021-2032)
- 10.2.1 China Viral Detection Revenue by Type (2021-2026)
- 10.2.2 China Viral Detection Revenue by Type (2027-2032)
- 10.3 China Viral Detection Revenue Share by Type (2021-2032)
- 10.4 China Viral Detection Revenue by Application (2021-2032)
- 10.4.1 China Viral Detection Revenue by Application (2021-2026)
- 10.4.2 China Viral Detection Revenue by Application (2027-2032)
- 10.5 China Viral Detection Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Viral Detection Revenue (2021-2032)
- 11.2 Asia Viral Detection Revenue by Type (2021-2032)
- 11.2.1 Asia Viral Detection Revenue by Type (2021-2026)
- 11.2.2 Asia Viral Detection Revenue by Type (2027-2032)
- 11.3 Asia Viral Detection Revenue Share by Type (2021-2032)
- 11.4 Asia Viral Detection Revenue by Application (2021-2032)
- 11.4.1 Asia Viral Detection Revenue by Application (2021-2026)
- 11.4.2 Asia Viral Detection Revenue by Application (2027-2032)
- 11.5 Asia Viral Detection Revenue Share by Application (2021-2032)
- 11.6 Asia Viral Detection Revenue by Country
- 11.6.1 Asia Viral Detection Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Viral Detection Revenue by Country (2021-2026)
- 11.6.3 Asia Viral Detection Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Viral Detection Revenue (2021-2032)
- 12.2 SAMEA Viral Detection Revenue by Type (2021-2032)
- 12.2.1 SAMEA Viral Detection Revenue by Type (2021-2026)
- 12.2.2 SAMEA Viral Detection Revenue by Type (2027-2032)
- 12.3 SAMEA Viral Detection Revenue Share by Type (2021-2032)
- 12.4 SAMEA Viral Detection Revenue by Application (2021-2032)
- 12.4.1 SAMEA Viral Detection Revenue by Application (2021-2026)
- 12.4.2 SAMEA Viral Detection Revenue by Application (2027-2032)
- 12.5 SAMEA Viral Detection Revenue Share by Application (2021-2032)
- 12.6 SAMEA Viral Detection Revenue by Country
- 12.6.1 SAMEA Viral Detection Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Viral Detection Revenue by Country (2021-2026)
- 12.6.3 SAMEA Viral Detection Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst